Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationMatthias Gückenberger, Piet Ost, Yolande Lievens et al.|The Lancet Oncology|2020Cited by 1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentYolande Lievens, Wendy A. Woodward, Matthias Gückenberger et al.|Radiotherapy and Oncology|2020Cited by 646
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung CancerA. Ashworth, George Rodrigues, Andrew J. Warner et al.|Clinical Lung Cancer|2014Cited by 437
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized diseaseGabriele Calaminus, Didier Frappaz, Rolf‐Dieter Kortmann et al.|Neuro-Oncology|2013Cited by 371
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statementMatthias Gückenberger, David A. Palma, Claus Belka et al.|Radiotherapy and Oncology|2020Cited by 227